- Report
- May 2025
- 50 Pages
Global
From €2426EUR$2,650USD£2,062GBP
- Report
- March 2022
- 324 Pages
Global
From €8696EUR$9,500USD£7,391GBP
Nefopam is an analgesic drug used to treat moderate to severe pain. It is a centrally acting non-opioid analgesic, meaning it does not act on the opioid receptors in the brain. Nefopam is a synthetic compound that is structurally related to the opioid analgesic pentazocine. It is available in oral and intravenous formulations and is used to treat a variety of pain conditions, including postoperative pain, cancer pain, and neuropathic pain. Nefopam is also used to treat muscle spasms and to reduce fever.
Nefopam is a relatively new analgesic drug and is not widely used in many countries. It is not available in the United States, but is available in some European countries, including France, Germany, and the United Kingdom. Nefopam is also available in some Asian countries, including Japan, South Korea, and Taiwan.
Some companies in the Nefopam market include Sanofi, Teva Pharmaceuticals, and Mylan. Show Less Read more